Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials - Concepedia

Concepedia

Publication | Open Access

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

DOI Full Paper Access

236

Citations

13

References

2017

Year

Ira M. Jacobson, Eric Lawitz, Edward Gane, Bernard E Willems, Peter Ruane, Ronald Nahass, Sergio Borgia, Stephen D. Shafran, Kimberly Workowski, Brian L. Pearlman,

Gastroenterology

HepatologyViral HepatitisAntiviral Drug DevelopmentRandomized TrialsHepatitisVirologyAntiviral TherapyChronic Hcv InfectionChronic Viral InfectionInfection ControlAntiviral DrugMedicinePhase 3

References

	Year	Citations

Page 1

Page 1